ATRX and astrocytoma (excluding glioblastoma): Hu et al. [36] found that ATRX inactivation led to immune checkpoint upregulation and altered cytokine/chemokine expression, fostering an immunosuppressive response in IDH1R132H/TP53mut astrocytoma and enhancing tumor aggressiveness.